This opportunity is no longer accepting applications.
grant NIH/NIAID 139

Rapid Diagnostic Assays for Self-Monitoring of Acute or Rebound HIV-1 Infection

This grant opportunity accepts Phase I and Fast Track proposals, but not Direct-to-Phase II proposals. It anticipates awarding 4-5 grants. Phase I funding offers $300,000 per year for up to 2 years, and Phase II funding offers up to $2 million total for up to 3 years. The grant focuses on developing domestic innovations to combat HIV in the United States, supporting the goal of a 90% reduction…

Phase I and Fast Track proposals will be accepted.\nDirect-to-Phase II proposals will not be accepted.\nNumber of anticipated awards: 4-5\nBudget (total costs):\nPhase I: $ 300,000 per year for up to 2 years\nPhase II: $ 2 million total for up to 3 years\nBackground\nAn estimated 1.1 million peo…

Funding Source

Agency: National Institutes of Health
Program: SBIR

Dates

Opportunity Released: August 2, 2024
Open for Submission: August 2, 2024
Application Window Closes: October 18, 2024

Documents

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.